Research Article
Activation of GABAB Receptor Suppresses Diabetic Neuropathic Pain through Toll-Like Receptor 4 Signaling Pathway in the Spinal Dorsal Horn
Figure 4
The protein expression of Myd88, TLR4, and NF-κBp65 in each group. (a) Myd88 in the control (), DNP (), DNP + LPS-RS (TLR4 antagonist, ), DNP + baclofen (GABAB receptor agonist, ), and DNP + saclofen (GABAB receptor blocker, ) groups. (b) NF-κBp65 in the control (), DNP (), DNP + LPS-RS (TLR4 antagonist, ), DNP + MIP (Myd88 antagonist, ), DNP + baclofen (GABAB receptor agonist, ), and DNP + saclofen (GABAB receptor blocker, ) groups. (c) TLR4 in the control, DNP, DNP + baclofen (GABAB receptor agonist), and DNP + saclofen (GABAB receptor blocker) groups. ; .
(a) |
(b) |
(c) |